Teng Wei Chen

Director/Board Member at AIMFINITY INVESTMENT CORP. I

55 year

Finance

Consumer Services

Profile

Teng Wei Chen is an Independent Director at Aimfinity Investment Corp.
I and Inkstone Feibo Acquisition Corp.
He is also a Director at New-Shine Biomedical Co., Ltd.
Dr. Chen holds a doctorate degree from China Medical University (Taiwan).

Teng Wei Chen active positions

Companies	Position	Start
AIMFINITY INVESTMENT CORP. I	Director/Board Member	17/03/2023
Inkstone Feibo Acquisition Corp. Inkstone Feibo Acquisition Corp. Financial ConglomeratesFinance Inkstone Feibo Acquisition Corp. is a blank check company, which engages in effecting a merger, share exchange, asset acquisition, share purchase, reorganization or similar business combination with one or more businesses. It focuses on opportunities in biotechnology and green technology industries with an emphasize on environmental, social, and governance (ESG) practices in the United States and Taiwan. The company was founded on April 20, 2022 and is headquartered in Wilmington, DE.	Director/Board Member	-
New-Shine Biomedical Co., Ltd.	Director/Board Member	01/01/2018

All active positions of Teng Wei Chen

Training of Teng Wei Chen

China Medical University (Taiwan)

Doctorate Degree

Experiences
Positions held

Active

Inactive

Listed companies

Private companies

See the detail of Teng Wei Chen's experience

Connections

1st degree connections

1st degree companies

Male

Female

Members of the board

Executives

See the personal network

Linked companies

Listed companies	1
AIMFINITY INVESTMENT CORP. I	Finance

Private companies	2
Inkstone Feibo Acquisition Corp. Inkstone Feibo Acquisition Corp. Financial ConglomeratesFinance Inkstone Feibo Acquisition Corp. is a blank check company, which engages in effecting a merger, share exchange, asset acquisition, share purchase, reorganization or similar business combination with one or more businesses. It focuses on opportunities in biotechnology and green technology industries with an emphasize on environmental, social, and governance (ESG) practices in the United States and Taiwan. The company was founded on April 20, 2022 and is headquartered in Wilmington, DE.	Finance
New-Shine Biomedical Co., Ltd.